Spatium Medical B.V. closes €5 million financing round to bring smart insufflation technology to operating theatres in Europe and the USA
Rotterdam-based company Spatium Medical B.V., a pioneering MedTech spinoff from Erasmus MC, has successfully closed a €5 million financing round. This round includes new investors InnovationQuarter and Demcon Investment Fund and continued support from and the existing investors: Van Herk Ventures and Swanbridge Capital, and Erasmus MC TTO. The financing round is made possible with the Innovation Credit from the Netherlands Enterprise Agency (RVO).
Since the 1990’s, the number of laparoscopic surgeries has been ever growing, drastically reducing patient recovery time. However, the use of pressurized CO2 gas to create workspace for the surgeon, is not without consequences. Spatium Medical provides a solution by bringing smart, personalised insufflation to the world of laparoscopy.
The unique features of Spatium Medical’s product enable the surgeon to choose the right pressure for each individual patient, lowering the burden and reducing recovery time. It ensures stability of the surgical workspace, improving safety during the procedure. On top of that, it adjusts to mechanical ventilation. In other words, the technology is “breathing with the patient”, reducing patient burden and lowering the risk of complications.
This financing round will allow Spatium Medical to finalise the development of the smart insufflation device and to complete clinical studies in a number of hospitals. This will result in the certified product that will give patients access to improved surgical outcomes. Spatium Medical, recently incorporated in March 2022, is aiming to launch the innovative product in 2026.
Willem Mees van der Bijl, CEO of Spatium Medical: “The collaboration between the new and existing investors, the Netherlands Enterprise Agency (RVO) team and the Spatium Medical team has been invaluable. Not only in closing this important financial round, but also in sharing knowledge and expertise. This enables us to bring this innovative technology, developed here in Rotterdam, to the point where it will become the next standard of care for minimal invasive surgeries worldwide. Very exciting!”
Date: September 16, 2024
Source: Spatium Medical
